More News

24 May 2007 Organon and Philips team up to study drug effects at the molecular level
24 May 2007 ThromboGenics plans to absorb Belgian subsidiary Thromb-X
23 May 2007 Inovio Biomedical's DNA Delivery Technology Significantly Enhances Potency of Gene-Based Prostate Cancer Vaccine
23 May 2007 Scil Technology GmbH obtained Competent Authority Approval for Phase II Periodontitis Study
23 May 2007 Phase 1b insulin clinical trial commenced
23 May 2007 New Agreement Boosts Pipeline for Synosia Therapeutics
23 May 2007 Abbott Announces Positive Nine-Month Results from the World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
23 May 2007 Lupin Pharmaceuticals, Inc. Receives US FDA Approval for Ziprasidone HCl Capsules
22 May 2007 Sandoz Receives FDA Approval for Generic Toprol XL(R) 50 mg Tablet
22 May 2007 Nektar Therapeutics Announces Phase 2a Clinical Results Regarding the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative Hospital-Acquired Pneumonia Presented at the Annual American Thoracic Society International Conference
22 May 2007 Oculus Initiates Patient Enrollment in Phase II Study of Microcyn(R) Technology for Treatment of Mild Diabetic Foot Infections
22 May 2007 Oculus Initiates Patient Enrollment in Phase II Study of Microcyn(R) Technology for Treatment of Mild Diabetic Foot Infections
22 May 2007 Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at AUA Annual Meeting
22 May 2007 Medtronic Announces Start of 8,800-Patient Clinical Trial Evaluating Drug-Eluting Stent Safety
21 May 2007 Sun Pharmaceutical Industries Agrees to Acquire Taro Pharmaceutical Industries in Transaction Valued at $454 Million
19 May 2007 KV Pharmaceutical Company (KVA) Announces Approval for Two Strengths of Generic Versions of Toprol-XL(R)
18 May 2007 Roche and Siena Biotech S.p.A. Enter Research Collaboration Agreement in Neurodegenerative Diseases
17 May 2007 Next Generation Nasal Spray Against Influenza: Clinical Phase I Study Started With FLUVACCdelNS1
17 May 2007 Organon and Medarex announce biotherapeutics development agreement
17 May 2007 Glenmark receives US FDA approval to market generic
17 May 2007 CollaGenex Pharmaceuticals and QuatRx Pharmaceuticals Announce Agreement for the Development and Commercialization of Becocalcidiol
17 May 2007 Ranbaxy Receives Tentative FDA Approval for Fexofenadine Hydrochloride Tablets
16 May 2007 Proteros Biostructures and Boehringer Ingelheim Pharmaceuticals Enter into Protein Crystallography Agreement
16 May 2007 Lupin Pharmaceuticals, Inc. Receives US FDA Approval for Simvastatin Tablets
15 May 2007 Skyepharma PLC and Sciele Pharma Announce Successful Completion of New Sular(R) Formulation Clinical Trial Programme

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top